Blog
RSS FeedPosted by Michael Wonder on 16 Sep 2021
Drug makers see disaster in Medicare negotiating prices. Don’t listen to them.
16 September 2021 - The pharmaceutical industry, bizarrely, told the American people this week that allowing Medicare to negotiate drug ...
Posted by Michael Wonder on 15 Sep 2021
Drug prices measure blocked in House Committee as Democrats splinter
15 September 2021 - Provision of $3.5 trillion budget package would allow Medicare to negotiate over the cost of prescriptions. ...
Posted by Michael Wonder on 14 Sep 2021
Drug prices and value of oncology drugs in Italy
13 September 2021 - The main objective of this study was to evaluate the potential role of efficacy data and other ...
Posted by Michael Wonder on 14 Sep 2021
Moderate House Democrats threaten drug pricing bill in House panel
14 September 2021 - Three moderate House Democrats announced that they would vote against their party's legislation to lower drug ...
Posted by Michael Wonder on 14 Sep 2021
Biden drug pricing plan seeks to balance access and innovation
13 September 2021 - On Thursday 9 September, Health and Human Services Secretary Xavier Becerra publicly released the Biden Administration’s ...
Posted by Michael Wonder on 14 Sep 2021
Branded price variation in the United States drug market, 2010 to 2019
13 September 2021 - Branded drug prices command considerable attention in the United States yet defining a drug’s price is not ...
Posted by Michael Wonder on 13 Sep 2021
1 October 2021 price disclosure confirmed prices
13 September 2021 - Confirmed 1 October 2021 prices resulting from the 2021 October cycle of price disclosure have now been ...
Posted by Michael Wonder on 12 Sep 2021
Biden Administration’s prescription drug pricing plan promotes incremental change, not overhaul of system
12 September 2021 - On Thursday, September 9th, the White House released a long awaited plan to reduce prescription drug ...
Posted by Michael Wonder on 11 Sep 2021
Estimated savings from international reference pricing for prescription drugs
10 September 2021 - High prescription drug prices have important implications for health care spending, patient financial burden, and adherence. ...
Posted by Michael Wonder on 09 Sep 2021
Senate considers pegging Medicare drug prices to deeply discounted Veterans Affairs rates
9 September 2021 - Senate lawmakers are actively considering pegging the prices Medicare pays for drugs to those drug makers ...
Posted by Michael Wonder on 09 Sep 2021
Biden Administration unveils plan to cut prescription drug prices
9 September 2021 - The Department of Health and Human Services plan supports legislation to empower the government to negotiate Medicare ...
Posted by Michael Wonder on 09 Sep 2021
Health funds reject claims hospitals hit by prostheses reforms
9 September 2021 - Health insurers say private hospital operators will not be left out of pocket, rejecting claims they ...
Posted by Michael Wonder on 08 Sep 2021
Congress is ready to dig into drug prices
7 September 2021 - After months of drama and procedural votes, Congress is about to dive into the legislative process on ...
Posted by Michael Wonder on 07 Sep 2021
To lower drug costs, define ‘cost’ to mean net cost after rebates
7 September 2021 - In what could be a turning point in the prescription drug debate, President Biden has made ...
Posted by Michael Wonder on 06 Sep 2021
Democrats’ plans to introduce prescription drug pricing reform face formidable obstacles
6 September 2021 - For years, reducing prescription drug prices has been a policy goal of (mostly Democratic) legislators at the ...